Reliance buys majority stake in online pharmacy Netmeds for $83 million

0

BENGALURU (Reuters) – Reliance Industries Ltd <RELI.NS> has acquired a majority stake in online pharmacy Netmeds for about 6.2 billion rupees ($83.08 million) in cash, days after e-commerce giant Amazon.com Inc <AMZN.O> launched an online drug sales service in India.

The oil-to-telecoms conglomerate said https://www.bseindia.com/xml-data/corpfiling/AttachLive/cd4afca2-0bb5-4744-8ccb-f37a05fa65f2.pdf late on Tuesday its investment represents about 60% holding in Vitalic Health Pvt. Ltd. and 100% direct ownership of its subsidiaries.

Vitalic and its subsidiaries, collectively known as Netmeds, were incorporated in 2015. Netmeds is a licensed e-pharma portal that offers authenticated prescription and over the counter (OTC) medicine along with other health products in India.

The COVID-19 crisis, which spurred a wave of online shopping, has led to increased competition between Amazon, Walmart-owned Flipkart, Reliance’s upstart online grocery service, JioMart and a range of other smaller players for a share in the world’s second most populous country.

India is yet to finalize regulations for online drug sales, or e-pharmacies, but growth of online sellers such as Medlife, Netmeds, Temasek-backed PharmEasy and Sequoia Capital-backed 1mg has threatened traditional drug stores.

Many trader groups are against e-pharmacies, saying they would lead to sale of medicines without proper verification.

(Reporting by Bhargav Acharya and Anirudh Saligrama in Bengaluru; Editing by Shinjini Ganguli)

Share

LEAVE A REPLY

Please enter your comment!
Please enter your name here


By submitting this form, you are consenting to receive marketing emails from: News India Times | Desi Talk Headlines | Desi Talk Chicago, 35 JOURNAL SQ, JERSEY CITY, NJ, 07306, http://www.newsindiatimes.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact